NCT07271433Completed
Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
Use of continuous glucose monitor (CGM) in post kidney transplant patients to better assess changes in glucose levels post kidney transplant
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 20 (actual)
- First submitted
- 26 Nov 2025
- Start date
- 29 Jan 2024
- Primary completion date
- 12 Nov 2024
- Lead sponsor
- The Cleveland Clinic
- Diseases
- Type 2 diabetes
- NCT number
- NCT07271433
What you commit to
- Study type: Observational
- Participants enrolled: 20
- From 29 Jan 2024 to the primary completion date, 12 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Simultaneous pancreas-kidney transplant
Other illness
- Allergy to Freestyle Libre components including adhesive
Lab values
- Blood dyscrasias that prevent hemoglobin A1c interpretation
Other
- Use of vitamin C at doses 500 mg or greater
- Lack of mobile app accessibility
- Rapid prednisone taper
Who the study is looking for
- Sex: men and women
- Ethnicity: all ethnic groups
- Age: ≥ 18
- Known type 2 diabetes before kidney transplant
- Kidney transplant alone
- On multiple daily insulin injection
- Standard prednisone taper
- Smart phone - compatible with the LibreView App
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Cleveland Clinic Foundation Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.